Cargando…
Plant-Produced Monoclonal Antibody as Immunotherapy for Cancer
Plant-based products have expanded to include cancer immunotherapy, which has made great strides over recent years. Plants are considered inexpensive and facile production platforms for recombinant monoclonal antibody (mAb) due to the latest advancements and diversification of transgenic techniques....
Autores principales: | Nessa, Meher Un, Rahman, Md. Atiar, Kabir, Yearul |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7468595/ https://www.ncbi.nlm.nih.gov/pubmed/32908881 http://dx.doi.org/10.1155/2020/3038564 |
Ejemplares similares
-
Production of Monoclonal Antibodies in Plants for Cancer Immunotherapy
por: Moussavou, Ghislain, et al.
Publicado: (2015) -
Structural basis of checkpoint blockade by monoclonal antibodies in cancer immunotherapy
por: Lee, Ju Yeon, et al.
Publicado: (2016) -
Antibody therapy: Substitution-immunomodulation -monoclonal immunotherapy
por: Mehra, Narinder K.
Publicado: (2019) -
TP53 Arg72Pro and XPD Lys751Gln Gene Polymorphisms and Risk of Lung Cancer in Bangladeshi Patients
por: Nairuz, Tahsin, et al.
Publicado: (2020) -
Immunotherapy against Systemic Fungal Infections Based on Monoclonal Antibodies
por: Boniche, Camila, et al.
Publicado: (2020)